comparemela.com

Latest Breaking News On - Nodify lung nodule risk assessment - Page 4 : comparemela.com

Biodesix, Inc (NASDAQ:BDSX) Sees Significant Drop in Short Interest

Biodesix, Inc. (NASDAQ:BDSX – Get Free Report) saw a large drop in short interest in the month of November. As of November 30th, there was short interest totalling 134,100 shares, a drop of 14.7% from the November 15th total of 157,300 shares. Based on an average daily trading volume, of 67,900 shares, the short-interest ratio […]

Biodesix, Inc (NASDAQ:BDSX) Short Interest Update

Biodesix, Inc. (NASDAQ:BDSX – Get Free Report) was the recipient of a significant drop in short interest during the month of September. As of September 30th, there was short interest totalling 143,900 shares, a drop of 37.3% from the September 15th total of 229,600 shares. Based on an average daily volume of 78,500 shares, the […]

Short Interest in Biodesix, Inc (NASDAQ:BDSX) Declines By 13 3%

Biodesix, Inc. (NASDAQ:BDSX – Get Free Report) was the target of a large decline in short interest in the month of August. As of August 31st, there was short interest totalling 180,700 shares, a decline of 13.3% from the August 15th total of 208,300 shares. Based on an average trading volume of 73,600 shares, the […]

Critical Analysis: Biodesix (NASDAQ:BDSX) & BioNexus Gene Lab (NASDAQ:BGLC)

BioNexus Gene Lab (NASDAQ:BGLC – Get Free Report) and Biodesix (NASDAQ:BDSX – Get Free Report) are both small-cap medical companies, but which is the superior investment? We will contrast the two businesses based on the strength of their earnings, profitability, analyst recommendations, valuation, institutional ownership, dividends and risk. Profitability This table compares BioNexus Gene Lab […]

Biodesix, Inc (NASDAQ:BDSX) Sees Large Decline in Short Interest

Biodesix, Inc (NASDAQ:BDSX) Sees Large Decline in Short Interest
themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.